Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15585857rdf:typepubmed:Citationlld:pubmed
pubmed-article:15585857lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:15585857lifeskim:mentionsumls-concept:C0040648lld:lifeskim
pubmed-article:15585857lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:15585857lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:15585857lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:15585857lifeskim:mentionsumls-concept:C1332714lld:lifeskim
pubmed-article:15585857lifeskim:mentionsumls-concept:C0206120lld:lifeskim
pubmed-article:15585857lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:15585857lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:15585857lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:15585857lifeskim:mentionsumls-concept:C1546857lld:lifeskim
pubmed-article:15585857lifeskim:mentionsumls-concept:C1556066lld:lifeskim
pubmed-article:15585857lifeskim:mentionsumls-concept:C1619636lld:lifeskim
pubmed-article:15585857lifeskim:mentionsumls-concept:C1514873lld:lifeskim
pubmed-article:15585857pubmed:issue12lld:pubmed
pubmed-article:15585857pubmed:dateCreated2004-12-8lld:pubmed
pubmed-article:15585857pubmed:abstractTextAg-specific immune tolerance results from the induction of cellular mechanisms that limit T cell responses to selective Ags. One of these mechanisms is characterized by attenuated proliferation and decreased IL-2 production in fully stimulated CD4(+) Th cells and is denoted T cell anergy. We report the identification of the early growth response gene (Egr-2; Krox-20), a zinc-finger transcription factor, as a key protein required for induction of anergy in cultured T cells. Gene array screening revealed high Egr-2 expression distinctly persists in anergized but not proliferating murine A.E7 T cells. In contrast, Egr-1, a related family member induced upon costimulation, displays little or no expression in the anergic state. IL-2-mediated abrogation of anergy causes rapid depletion of Egr-2 protein. Full stimulation of anergic A.E7 T cells fails to enhance IL-2 and Egr-1 expression, whereas Egr-2 expression is greatly increased. Silencing Egr-2 gene expression by small interfering RNA treatment of cultured A.E7 T cells before incubation with anti-CD3 alone prevents full induction of anergy. However, small interfering RNA-mediated depletion of Egr-2 5 days after anergy induction does not appear to abrogate hyporesponsiveness to stimulation. These data indicate that sustained Egr-2 expression is necessary to induce a full anergic state through the actions of genes regulated by this transcription factor.lld:pubmed
pubmed-article:15585857pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585857pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585857pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585857pubmed:languageenglld:pubmed
pubmed-article:15585857pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585857pubmed:citationSubsetAIMlld:pubmed
pubmed-article:15585857pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585857pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585857pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585857pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585857pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585857pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585857pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585857pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585857pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585857pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585857pubmed:statusMEDLINElld:pubmed
pubmed-article:15585857pubmed:monthDeclld:pubmed
pubmed-article:15585857pubmed:issn0022-1767lld:pubmed
pubmed-article:15585857pubmed:authorpubmed-author:CzechMichael...lld:pubmed
pubmed-article:15585857pubmed:authorpubmed-author:RossiniAldo...lld:pubmed
pubmed-article:15585857pubmed:authorpubmed-author:GreinerDale...lld:pubmed
pubmed-article:15585857pubmed:authorpubmed-author:PhillipsNancy...lld:pubmed
pubmed-article:15585857pubmed:authorpubmed-author:MordesJohn...lld:pubmed
pubmed-article:15585857pubmed:authorpubmed-author:HarrisJohn...lld:pubmed
pubmed-article:15585857pubmed:authorpubmed-author:BishopKenneth...lld:pubmed
pubmed-article:15585857pubmed:issnTypePrintlld:pubmed
pubmed-article:15585857pubmed:day15lld:pubmed
pubmed-article:15585857pubmed:volume173lld:pubmed
pubmed-article:15585857pubmed:ownerNLMlld:pubmed
pubmed-article:15585857pubmed:authorsCompleteYlld:pubmed
pubmed-article:15585857pubmed:pagination7331-8lld:pubmed
pubmed-article:15585857pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:meshHeadingpubmed-meshheading:15585857...lld:pubmed
pubmed-article:15585857pubmed:year2004lld:pubmed
pubmed-article:15585857pubmed:articleTitleEarly growth response gene-2, a zinc-finger transcription factor, is required for full induction of clonal anergy in CD4+ T cells.lld:pubmed
pubmed-article:15585857pubmed:affiliationProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA.lld:pubmed
pubmed-article:15585857pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15585857pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15585857pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:15585857pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:13654entrezgene:pubmedpubmed-article:15585857lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15585857lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585857lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585857lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585857lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585857lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585857lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585857lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585857lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585857lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585857lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585857lld:pubmed